Home » Topics » Cancer, BioWorld Science

Cancer, BioWorld Science
RSS

FDA accepts IND for MN-029

July 2, 2004

Aplidin receives orphan drug status for ALL

July 2, 2004

Alimta receives positive opinion in Europe

July 1, 2004

Sanofi-Synthelabo and Pfizer conclude agreement on divestment of Campto

July 1, 2004

Preliminary data on Exherin in patients with solid tumors

July 1, 2004

Celecoxib and a poxvirus-based vaccine improve survival in mice with multiple intestinal neoplasia

July 1, 2004

Palifermin NDA submitted for oral mucositis

July 1, 2004

Preclinical progress in DOS-47 development program

June 30, 2004

First of two phase I studies for SNS-595

June 30, 2004

Peregrine and Affitech achieve first milestone in collaboration

June 30, 2004

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...